The use of biomarkers to guide precision treatment for tobacco use

This review summarizes the evidence to date on the development of biomarkers for personalizing the pharmacological treatment of combustible tobacco use. First, the latest evidence on FDA-approved medications is considered, demonstrating that, while these medications offer real benefits, they do not...

Descripción completa

Detalles Bibliográficos
Autores principales: Siegel, Scott D., Tindle, Hilary A., Bergen, Andrew W., Tyndale, Rachel F., Schnoll, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10121195/
https://www.ncbi.nlm.nih.gov/pubmed/37089247
http://dx.doi.org/10.1016/j.addicn.2023.100076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10121195/
https://www.ncbi.nlm.nih.gov/pubmed/37089247
http://dx.doi.org/10.1016/j.addicn.2023.100076

Ejemplares similares